Monday, December 6, 2021
HomeLatest NewsCovid-19CDC Expands Eligibility for COVID-19 Booster Shots

CDC Expands Eligibility for COVID-19 Booster Shots

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for a booster shot of COVID-19 vaccines in certain populations. The Food and Drug Administration’s (FDA) and CDC’s recommendation for use are important steps forward as we work to stay ahead of the virus and keep Americans safe.

For individuals who received a Pfizer-BioNTech or Moderna COVID-19 vaccine, the following groups are eligible for a booster shot at 6 months or more after their initial series:

For the nearly 15 million people who got the Johnson & Johnson COVID-19 vaccine, booster shots are also recommended for those who are 18 and older and who were vaccinated two or more months ago.

There are now booster recommendations for all three available COVID-19 vaccines in the United States. Eligible individuals may choose which vaccine they receive as a booster dose. Some people may have a preference for the vaccine type that they originally received and others, may prefer to get a different booster. CDC’s recommendations now allow for this type of mix and match dosing for booster shots.

Millions of people are newly eligible to receive a booster shot and will benefit from additional protection. However, today’s action should not distract from the critical work of ensuring that unvaccinated people take the first step and get an initial COVID-19 vaccine. More than 65 million Americans remain unvaccinated, leaving themselves – and their children, families, loved ones, and communities– vulnerable.

Available data right now show that all three of the COVID-19 vaccines approved or authorized in the United States continue to be highly effective in reducing risk of severe disease, hospitalization, and death, even against the widely circulating Delta variant. Vaccination remains the best way to protect yourself and reduce the spread of the virus and help prevent new variants from emerging.

The following is attributable to Dr. Walensky:

“These recommendations are another example of our fundamental commitment to protect as many people as possible from COVID-19. The evidence shows that all three COVID-19 vaccines authorized in the United States are safe – as demonstrated by the over 400 million vaccine doses already given. And, they are all highly effective in reducing the risk of severe disease, hospitalization, and death, even in the midst of the widely circulating Delta variant.”

Stay Connected

Unified Voice Newsletter

Events This Month

december

07dec1:00 pm2:00 pmOpioids and Treatment Services in South DakotaSDAHO Webinar1:00 pm - 2:00 pm CST Event Type :Education Events,Webinar

07dec2:00 pm3:00 pmProject Firstline – Cleaning is More than a Swiffer and Mr. CleanGPQIN Webinar2:00 pm - 3:00 pm CST Event Type :Education Events,Webinar

08dec11:00 am12:00 pmPAMA Lab Test Private Payor Rate Reporting—What Clinical Labs Need to Know Now to Avoid Future PenaltiesSDAHO Webinar11:00 am - 12:00 pm CST Event Type :Education Events,Webinar

08dec12:00 pm1:00 pmThe Importance of Multidisciplinary Teams - How Project Firstline Can Support Your Facility’s Infection Prevention and Control Training NeedsAHA Webinar12:00 pm - 1:00 pm CST Event Type :Education Events,Webinar

08dec1:00 pm2:00 pmCMS Open Door Forum: Provider Requirements under the No Surprises Actcms event1:00 pm - 2:00 pm CST Event Type :Community Events,Education Events

X


By submitting this form, you are consenting to receive marketing emails from: SDAHO, 3708 W Brooks Place, Sioux Falls, SD, 57106, http://sdaho.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact